Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flibanserin Neuroimaging in HSDD
NCT02770768Terminated
- Sponsor
- University of Chicago
- Start
- Oct 2016
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) comparing Flibanserin with Placebo (2 arms). Primary endpoint: EEG Results: Evoked Brain Potentials at 8 weeks. Started Oct 2016; status: terminated.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT02770768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770768.